The side effects that have emerged in a large, late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller initial studies, a positive sign for one of the pioneers in the career. for a drink. The partners have not …
Read More »Why Johnson & Johnson and Eli Lilly have stopped late-stage Covid-19 clinical trials
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: October 14, 2020 9:30:43 pm Health workers in a Covid-19 ward in New Delhi The quest to find a quick and effective treatment for Covid-19 suffered two setbacks in a 24-hour span after two major US drug …
Read More »Covid-19: what you need to know today
Johnson & Johnson has stopped the trial of its coronavirus vaccine candidate after an unexplained illness in one of the participants, although it was not immediately clear whether the person was part of the trial (or experimental group) receiving the injection, or the control group that does not (people in …
Read More »The government prepares the distribution plan. Who will get it first?
After ten months of a global pandemic, the search for a “safe and effective” vaccine against the new coronavirus continues. The central government expects between 400 and 500 million doses of the vaccine to be available in India by the middle of next year. Union Health Minister Dr. Harsh Vardhan …
Read More »Coronavirus | Vaccine priority based on occupational hazards, risk of exposure, says Harsh Vardhan
Harsh Vardhan said that “the authorization of emergency use for the COVID-19 vaccine will depend on data from clinical trials.” Union Health Minister Harsh Vardhan said on Sunday that his ministry will soon launch the FELUDA paper strip test for the diagnosis of SARS-CoV-2. This has been developed by CSIR-IGIB …
Read More »Covid-19 Cases India Latest News, Covid-19 Vaccine Tracker (Corona) Current News Update
Doctors and nurses on duty from COVID-19 protest against the North MCD administration for alleged non-payment of outstanding wages, at the Hindu Rao Hospital in New Delhi, on Friday, October 9, 2020 (Express photo by Amit Mehra) . Meanwhile, a handful of coronavirus vaccine candidates are nearing the end of …
Read More »Coronavirus | Active COVID-19 Cases Below 9 Lakh For Second Consecutive Day
Up to 18 states and Union Territories have recorded recovery rates above the national average, the ministry said. Active COVID-19 cases in India stayed below the nine lakh mark for the second day in a row and now constitute only 12.65 percent of the total number of cases, the Union …
Read More »Moderna to apply for continued EU approval for COVID-19 vaccine
Vaccine maker Moderna Inc will soon request real-time reviews of its experimental COVID-19 vaccine in Europe, days after the EU health regulator released ongoing reviews of its rivals’ injections. The drug developer said it was in talks with European countries and would send the same data it plans to send …
Read More »Covid-19 Vaccine Tracker: EU Seals New Deal, No Oxford Vaccine Side Effects Reported in India
Amid the ongoing fury of the Covid-19 pandemic, all eyes are on the launch of an effective vaccine. Vaccine producers are conducting clinical trials as countries close new deals. Aside from concerns about the safety of trial vaccines, the spate of deals has become a new concern, as wealthier nations …
Read More »Russia ready to approve second vaccine next week
Russia is set to register its second coronavirus vaccine on October 15, the vaccine developer said on Friday, according to a Reuters report. Developed by Vector’s State Research Center for Virology and Biotechnology, the experimental vaccine has recently completed its early-stage human trials. “The Ministry of Health of the Russian …
Read More »